Cell and Gene Therapy Catapult
Cell and Gene Therapy Catapult's Overview
The Cell and Gene Therapy Catapult (CGT Catapult) was established as an independent centre of excellence to advance the growth of the UK cell and gene therapy industry, by bridging the gap between scientific research and full-scale commercialisation. It works with academia, industry, and healthcare providers to develop and validate new technologies and processes, provide access to state-of-the-art manufacturing facilities, and support the development of the skilled workforce required for this rapidly evolving sector. CGT Catapult aims to make the UK the most compelling and logical choice for international partners to develop and commercialise these advanced therapies.
Where is Cell and Gene Therapy Catapult's Headquarters?
HQ Function
Serves as the central hub for corporate strategy, business development, regulatory affairs, collaborations, and engagement with government and international partners.
Notable Features:
Strategically located within Guy's Hospital, facilitating close collaboration with NHS clinical research and healthcare infrastructure.
Work Culture:
A dynamic, collaborative, and mission-driven environment focused on innovation and excellence. Employees are dedicated to advancing the cell and gene therapy field and making a tangible impact on healthcare.
HQ Significance:
The London HQ is pivotal for national and international engagement, connecting academic breakthroughs with industry expertise and investment. Its location provides access to a rich life sciences ecosystem.
Values Reflected in HQ: Collaboration (proximity to NHS and academia), Innovation (driving cutting-edge therapies), Excellence (high standards in operations and partnerships), and Impact (focus on patient benefit and industry growth).
Location:
While primarily focused on building the UK's cell and gene therapy industry, CGT Catapult has a significant global outlook. It actively collaborates with international companies, research institutions, and regulatory bodies to share best practices, attract inward investment, and help UK-based entities access global markets. It participates in international consortia and conferences, contributing to global standards and fostering a worldwide network for advanced therapies.
Street Address:
12th Floor, Tower Wing, Guy's Hospital, Great Maze Pond
City:
London
State/Province:
N/A
Country:
United Kingdom
Cell and Gene Therapy Catapult's Global Presence
Stevenage, Hertfordshire, UK
Address: CGT Catapult Manufacturing Centre, Gunnels Wood Road, Stevenage, Hertfordshire, SG1 2FX, UK
Located on the Stevenage Bioscience Catalyst campus, a key UK hub for life sciences, fostering collaboration and innovation in advanced therapy manufacturing.
Braintree, Essex, UK
Address: CGT Catapult, Units 7-8 Horizon 120 Business & Innovation Park, Braintree, Essex, CM77 7AF, UK
Addresses the critical skills gap in advanced therapy manufacturing, supporting talent development across the UK and particularly within the London-Stansted-Cambridge corridor.
Edinburgh, Scotland, UK
Address: CGT Catapult, Nine Edinburgh BioQuarter, Little France Road, Edinburgh, EH16 4UX, UK
Extends CGT Catapult's national reach, connecting Scottish innovation with UK-wide initiatives and resources in advanced therapies.
Buying Intent Signals for Cell and Gene Therapy Catapult
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
Executive Team of Cell and Gene Therapy Catapult
As of April 2025, Cell and Gene Therapy Catapult' leadership includes:
Investors of Cell and Gene Therapy Catapult
Cell and Gene Therapy Catapult has been backed by several prominent investors over the years, including:
Executive New Hires/Exits in the Last 12 Months
In the last 12 months, Cell and Gene Therapy Catapult appointed Dr John Brown CBE FRSE as its new Chair, succeeding Ian McCubbin. This change signifies continued strategic leadership evolution. Major C-suite appointments including the CBO, CFO, and CTO occurred in early 2023, slightly preceding this 12-month window but shaping the current executive team.
Departures
New Appointments:
Technology (Tech Stack) used by Cell and Gene Therapy Catapult
Discover the tools Cell and Gene Therapy Catapult uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Cell and Gene Therapy Catapult Email Formats and Examples
The most common email format used by Cell and Gene Therapy Catapult is firstname.lastname@ct.catapult.org.uk. Variations may exist but this is the predominant structure.
firstname.lastname@ct.catapult.org.uk
Format
jane.doe@ct.catapult.org.uk
Example
85%
Success rate
News and media
ct.catapult.org.uk • May 23, 2024
Cell and Gene Therapy Catapult and partners launch digital systems framework to optimise advanced therapy supply chains
The Cell and Gene Therapy Catapult (CGT Catapult) announced the launch of the Advanced Therapy Supply Chain Digital Systems Framework. This framework, developed with industry partners, aims to standardise and optimise digital systems in advanced therapy medicinal product (ATMP) supply chains, enhancing efficiency and patient access....more
ct.catapult.org.uk • April 25, 2024
Cell and Gene Therapy Catapult and Cytiva collaborate to industrialise viral vector manufacturing for cell and gene therapies
CGT Catapult and Cytiva are collaborating to advance the industrialisation of viral vector manufacturing. This partnership will focus on developing innovative technologies and processes to improve scalability, cost-effectiveness, and robustness of viral vector production for cell and gene therapies....more
ct.catapult.org.uk • November 2, 2023
Dr John Brown CBE FRSE appointed as new Chair of the Cell and Gene Therapy Catapult
The Cell and Gene Therapy Catapult announced the appointment of Dr John Brown CBE FRSE as its new Chair. Dr Brown brings a wealth of experience in the life sciences industry and will guide the Catapult in its mission to grow the UK's cell and gene therapy sector....more
Highperformr’s free tools for company research
Explore Employees by Region or Country
See where a company’s workforce is located, by country or region.
View Funding Details
View past and recent funding rounds with amounts and investors.
Understand Revenue Insights
Understand company revenue estimates and financial scale.
Track Active Job Openings
Track active roles and hiring trends to spot growth signals.
Review Product and Offerings
Discover what a company offers—products, platforms, and solutions.
Get SIC or NAICS Codes
Get the company’s official SIC and NAICS classifications.
Analyze Website Traffic Trends
Analyze visitor volume, engagement, and top traffic sources.
Discover Social Profiles and Engagement
Explore LinkedIn, Twitter, and other active social profiles.
Identify Top Competitors
Identify top competitors based on similar business traits.
Research and Discover Companies with Highperformr — Smarter, Faster
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
- Track intent signals to find buyers who are actively in-market
- Enrich contacts and companies instantly, no need to switch tools
- Automate workflows to stay ahead of every change
- Connect your CRM & tools for seamless data sync and activation
Thousands of companies, including Cell and Gene Therapy Catapult, are just a search away.